2023
Treatment Intensity and Outcomes in Elderly Patients with DLBCL Receiving First Line Therapy
Bair S, Narkhede M, Frosch Z, Chong E, Ermann D, Isufi I, Awan F, Chavez J, Bosma G, Abbott D. Treatment Intensity and Outcomes in Elderly Patients with DLBCL Receiving First Line Therapy. Blood 2023, 142: 68. DOI: 10.1182/blood-2023-187113.Peer-Reviewed Original ResearchReal-world progression-free survivalReal-world overall survivalMultivariate Cox regression analysisR-CHOPAlternative regimensAge 70Partial responseTreatment intensityComplete responseMedian ageElderly ptsMedian Charlson Comorbidity Index scoreMedian real-world overall survivalCharlson Comorbidity Index scoreHigh-risk IPI scoreLarge real-world studyAnthracycline-based chemoimmunotherapyHigh-risk IPIComorbidity Index scoreFirst-line therapyProgression-free survivalKaplan-Meier methodCox regression analysisLong-term outcomesLog-rank test
2020
Outcomes for allogeneic stem cell transplantation in refractory mycosis fungoides and primary cutaneous gamma Delta T cell lymphomas
Isufi I, Seropian S, Gowda L, Wilson LD, Roberts K, Girardi M, Perreault S, Foss F. Outcomes for allogeneic stem cell transplantation in refractory mycosis fungoides and primary cutaneous gamma Delta T cell lymphomas. Leukemia & Lymphoma 2020, 61: 2955-2961. PMID: 32643494, DOI: 10.1080/10428194.2020.1790555.Peer-Reviewed Original ResearchConceptsAllogeneic stem cell transplantationMF/SSTime of transplantStem cell transplantationT-cell lymphomaMedian followCell transplantationCell lymphomaPrimary cutaneous gamma-delta T-cell lymphomaCutaneous gamma-delta T-cell lymphomaGamma-delta T-cell lymphomaMF/SS patientsLong-term complete responseCutaneous T-cell lymphomaTotal skin electron beamRefractory mycosis fungoidesClinical complete remissionDisease-free survivalComplete remissionOverall survivalPartial responseSkin involvementComplete responseMycosis fungoidesSS patients